Karelle De Luca

Title: Inventor Karelle De Luca – Innovating Immunogenic Formulations

Introduction

Karelle De Luca, an inventive mind from Villette de Vienne, France, has made significant strides in the field of immunology. With a dedicated focus on developing innovative vaccine formulations, she holds a patent that is poised to impact the way vaccines are formulated and administered to a variety of target animals.

Latest Patents

Karelle De Luca's notable patent is titled "Immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants." This invention presents novel immunological and vaccine formulations that utilize a newly applied non-crosslinked polyacrylic acid polymer adjuvant. These adjuvants can be combined with a range of immunogens—including inactivated pathogens, attenuated pathogens, subunits, recombinant expression vectors, and plasmids—resulting in vaccines that are both safe and effective for a wide range of target animals, including humans and various species such as canines, felines, and bovines.

Career Highlights

Throughout her career, Karelle has worked for prominent companies in the pharmaceutical and animal health sectors, notably Sanofi Pasteur and Boehringer Ingelheim Animal Health USA Inc. Her experience in these reputable organizations has honed her skills and insights into vaccine development, enabling her to contribute significantly to advancements in immunogenic formulations.

Collaborations

Karelle has collaborated with distinguished colleagues, including Guillaume Rigaut and Alexis Guy André Lucien Parisot. These partnerships have facilitated a dynamic exchange of ideas, enriching the innovation process and leading to the successful development of her patented formulations.

Conclusion

Karelle De Luca exemplifies the spirit of innovation in the field of immunology. Her contributions through her patent in immunogenic formulations not only highlight her exceptional talent as an inventor but also emphasize the importance of collaboration in advancing scientific discoveries. As she continues to explore and innovate, her work is sure to pave the way for future breakthroughs in vaccine development.